News
State laws designed to preserve access to infertility treatment are taking effect, even as Republicans continue to debate ...
Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women’s health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic ...
Fertility treatment advocates have expressed concerns about a new Arkansas law they say is meant to cast doubt on the ...
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosteroneNo FDA-approved oral therapies currently exist for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results